LDL subfractions in acromegaly: Relation to growth hormone and insulin-like growth factor-I

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 59-65

  Tan, K C B ^a   Shiu, S W M ^a   Janus, E D ^a   Lam, K S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

acromegaly; cholesteryl ester transfer protein; growth hormone; hepatic lipase; insulin like growth factor I; lipoprotein lipase; small dense low density lipoprotein

Indexed keywords

CHOLESTEROL ESTER; GROWTH HORMONE; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ACROMEGALY; APOLIPOPROTEINS; BIOLOGICAL MARKERS; BODY MASS INDEX; BROMOCRIPTINE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCOPROTEINS; GROWTH HORMONE; HORMONE ANTAGONISTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RISK FACTORS; TRIGLYCERIDES;

EID: 0031041840     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06015-7     Document Type: Article

References (40)

1. McGuffin WL, Sherman BM, Roth J et al. Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med 1974;81:11.
2. Nabarro JDN. Acromegaly. Clin Endocrinol 1987;26:481
3. Takeda R, Tatami R, Ueda K, Sagara H, Nakabayashie H, Mabushi H. The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients. Acta Endocrinol, 1982;100:358.
4. Nikkila EA, Pelkonen R. Serum lipids in acromegaly. Metabolism 1975;74:829.
5. Lam KSL, Pang RWC, Janus ED, Kung AWC, Wang CCL. Serum apolipoprotein (a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis 1993;104:813.
6. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;260:1917.
7. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationship of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991;90:67.
8. Campos H, Genest JJ Jr, Blijlevens E, McNarama JR, Jenner JL, Ordovas JM, Wilson ONF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992;12:187.
9. Griffin BA, Freeman DJ, Tait GW et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein subfractions: relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241.
10. Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol 1995;75:53B.
11. Barakat HA, Carpenter JW, McClendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Diabetes 1990;39:1527.
12. Tan KCB, Cooper MB, Ling KLE et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 1995;133:273.
13. Reaven GM. Syndrome X: 6 years later. J Intern Med 1994;23(Suppl 736):13.
14. Hansen I, Tsalikian E, Beaufree B, Gerich J, Haymond M, Rizza R. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 1986;250:E269.
15. Karlander S, Vranic M, Efendic S. Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance. Diabetologia 1986;29:778.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976;72:248.
17. Ehnholm C, Kuusi T. Preparation, characterisation, and measurement of hepatic lipase. Methods Enzymol 1986;129:716.
18. Eckel RH, Goldberg IJ, Steiner L, Yost TJ, Paterniti JR. Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes 1988;37:610.
19. Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 1990;79:575.
20. Murase T, Yamada N, Ohsawa N, Kosaka K, Morita S, Yoshida S. Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism 1980;29:666.
21. Asayama K, Amemiya S, Kusano S, Kato K. Growth hormone induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism 1984;33:129.
22. Richelsen B, Pedersen SB, Borglum JD, Moller-Pedersen T, Jorgensen J, Jorgensen JO. Growth hormone treatment of obese women for 5 weeks: effect on body composition and adipose tissue lipoprotein lipase activity. Am J Physiol 1994;266:E211.
23. Ottosson M, Vikman-Adolfsson K, Enerback S, Elander A, Bjorntorp P, Eden S. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1995;80:936.
24. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 1995;6:291.
25. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255.
26. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993;362:73.
27. Bhatnagar D, Durington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 1993;98:25.
28. Inazu A, Koizumi J, Mabuchi H, Kajinami K, Takeda R. Enhanced cholesteryl ester protein activities and abnormalities of high density lipoproteins in familial hypercholesterolaemia. Horm Metab Res 1992;24:284.
29. Tall AR, Granot E, Brocia R et al. Accelerated transfer of cholesteryl esters in dyslipidaemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987;79:1217.
30. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991;21:161.
31. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease. Circulation 1990;82:495.
32. Zambon A, Austin A, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary heart disease. Arterioscler Thromb 1993;13:147.
33. Tan CE, Forster L, Caslake MJ et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipidaemic men and women. Arterioscler Thromb Vasc Biol 1995;15:1839.
34. Caslake MJ, Packard CJ, Series JJ, Yip B, Dagen MM, Shepherd J. Plasma triglyceride and low density lipoprotein metabolism. Eur J Clin Invest 1992;22:96.
35. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993;32:1687.
36. Deckelbaum RJ, Granot E, Oscgry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984;4:225.
37. Keller U, Miles JM. Growth hormone and lipids. Horm Res 1991;36(Suppl 1):36.
38. Rudling M, Norstede G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 1992;89:6983.
39. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogenous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741.
40. Griffin B, Farish E, Walsh D et al. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause. Clin Endocrinol 1993;39:463.